Results 131 to 140 of about 35,497 (235)

Rutin Stabilises β‐Catenin Through GSK3β Inhibition to Promote Hair Follicle Regeneration

open access: yesCell Proliferation, EarlyView.
Rutin directly binds to GSK3β, stabilising β‐catenin and activating Wnt/β‐catenin signalling to drive hair cycle.
Yanyan Zhang   +10 more
wiley   +1 more source

SARS‐CoV‐2 nucleocapsid protein variants have differential RNA chaperone activity

open access: yesThe FEBS Journal, EarlyView.
The SARS‐CoV‐2 nucleocapsid (N) protein facilitates RNA annealing through its RBD–IDR2–CTD region, identifying it as a functional RNA chaperone. The Omicron BA.5 variant shows reduced chaperone activity compared to the Wuhan wild‐type protein. Although phosphorylation has no effect on wild‐type N, phosphomimetic modification of BA.5 N restores its RNA ...
Sabrina Babl   +11 more
wiley   +1 more source

Decrease of GSK-3β Activity in the Anterior Cingulate Cortex of Shank3b−/− Mice Contributes to Synaptic and Social Deficiency

open access: gold, 2019
Mengmeng Wang   +10 more
openalex   +1 more source

mTORC2 facilitates endothelial cell senescence by suppressing Nrf2 expression via the Akt/GSK-3β/C/EBPα signaling pathway [PDF]

open access: bronze, 2018
Hanwei Yang   +9 more
openalex   +1 more source

EHD4 and ASAP2 are critical negative regulators of the claudin‐5‐based endothelial barrier

open access: yesThe FEBS Journal, EarlyView.
Cell‐surface CLDN‐5 protein levels can be evaluated using a probe that can bind to the extracellular domains of CLDN‐5. A probe derived from Clostridium perfringens enterotoxin allows us to isolate cells with high CLDN‐5 protein levels from a knockout cell library.
Yosuke Hashimoto   +8 more
wiley   +1 more source

The Effect of Chlorhexidine Mouthwash on Blood Pressure: A Systematic Review and Meta‐Analysis

open access: yesInternational Journal of Dental Hygiene, EarlyView.
ABSTRACT Aim This study evaluated the effect of rinsing with a chlorhexidine containing mouthwash (CHX‐MW) on blood pressure (BP), as compared to rinsing with a control MW or no MW, based on (randomised) controlled trials and observational studies in humans. PROSPERO CRD42020222495.
Lars S. J. Toonen   +5 more
wiley   +1 more source

IL‐2 silencing enables Tfh cell expansion during vaccination but is redundant for antibody production

open access: yesImmunology &Cell Biology, EarlyView.
Sustained IL‐2 production delays T follicular helper cell differentiation and germinal center formation but does not alter final antibody titers or antigen‐specific humoral immunity after vaccination. Created in BioRender. Burton, A. (2026) https://BioRender.com/paggz41 Abstract Vaccines stimulate protective humoral immunity by coordinating lymphocyte ...
Silvia Innocentin   +9 more
wiley   +1 more source

Nemolizumab in prurigo nodularis up to 100 weeks: OLYMPIA LTE interim analysis

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
In this interim analysis of the OLYMPIA long‐term extension trial, nemolizumab exhibited sustained efficacy and was well tolerated through 100 weeks, with most adverse events being mild/moderate. Patients showed clinically meaningful improvements in core signs and symptoms.
Franz J. Legat   +22 more
wiley   +1 more source

GSK-3β coordinates axonal microtubule organization through Shot and Tau. [PDF]

open access: yesProc Natl Acad Sci U S A
Voelzmann A   +8 more
europepmc   +1 more source

Severity bands for atopic dermatitis measures: Analysis from adult dupilumab randomized clinical trials

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
This analysis used a large clinical trial data set (>30,000 patient visits across >2800 patients) and novel statistical methodologies (including frequency cross‐over analysis and means based on spline regression) to develop severity threshold bands for clinician‐ and patient‐reported outcome measures for adults with moderate‐to‐severe atopic dermatitis.
Andreas Wollenberg   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy